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The relationship between headache and epilepsy is complex and despite the nature
of this association is not yet clear. In the last few years, it has been progressively
introduced the concept of the “ictal epileptic headache” that was included in the recently
revised International Classification of Headaches Disorders 3rd edition (ICHD-3-revised).
The diagnostic criteria for ictal epileptic headache (IEH) suggested in 2012 were quite
restrictive thus leading to the underestimation of this phenomenon. However, these
criteria have not yet been included into the ICHD-3 revision published in 2018, thus
creating confusion among both, physicians and experts in this field. Here, we highlight
the importance to strictly apply the original IEH criteria explaining the reasons through the
analysis of the clinical, historical, epidemiological and pathophysiological characteristics
of the IEH itself. In addition, we discuss the issues related to the neurophysiopathological
link between headache and epilepsy as well as to the classification of these epileptic
events as “autonomic seizure.”
Keywords: ictal epileptic headache, hemicrania epileptica, epilepsy, migraine, tension-type headache, EEG,
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HEADACHE, EPILEPSY, AND “ICTAL EPILEPTIC HEADACHE”
Headache and epilepsy are characterized by transient attacks of altered brain function. The links
between headache and epilepsy are complex and in the last century there have been several
attempts to improve the classification, the clinical characterization, and the physiopathology of
this association (1, 2).
In the 20th century, Sir W. R. Gowers, first suggested that “migraine is in the borderland of
epilepsy” (2), sharing some pathophysiological mechanisms, presenting themselves as dysfunctions
of neurotransmitters and ion channels. Indeed, these two conditions are common, often co-
morbid, with headache attacks in epilepsy, temporally related as pre-ictal, ictal, post-ictal, or
inter-ictal events. In addition, they can present with either visual, cognitive, sensorial and motor
signs/symptoms (1, 2). Furthermore, the concept of “headache” as “an epileptic headache” that “. . .
may even be the only clinical manifestation of idiopathic epilepsy” dates back from a long time ago.
Already in the pre-EEG era, Gowers stated that “. . . in extremely rare instances one affection may
develop while the other goes on,” (2). Nowadays, the availability of digital EEG recordings allow
us to state that chronic headache itself may occasionally represent an epilepsy condition and that
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often headache can represent the only ictal epileptic phenomenon
(i.e., ictal epileptic headache, IEH) (3–6).
The first description of IEH dates to the 1950s (7–10) but
the term migralepsy was coined 10 years later by Lennox and
Lennox (11) and become strongly rooted in the epileptological
culture, hindering the verification and awareness among experts
of the possible complete overlap of an epileptic seizure and
a cephalalgic event. In fact, following the introduction of the
migralepsy concept, an increasing number of ictal headaches
have been described (12–15) and it has been hypothesized that
the migralepsy sequence may not exist at all and that the initial
part of the “migralepsy” may merely be an “ictal headache”
followed by other ictal autonomic, sensory, motor or psychic
signs/symptoms, being thus classified in fact as “hemicrania
epileptica” (16).
Although the revised International Classification of
Headaches Disorders 3rd edition (ICHD-3) now includes
the term “ictal epileptic headache” (17), it does not take into
account the original clinical criteria (3). Indeed, since the
first demonstration (13) of the immediate remission of EEG
abnormalities and of the headache after the administration
of intravenous anti-epileptic drug, over than 30 cases of IEH
have been reported (3–6, 12–16, 18–34). These papers suggest
that a diagnosis of IEH is possible when all the following
criteria occur (3): (a) headache lasting minutes, hours, or days,
headache that is ipsilateral or contralateral (if the headache is not
generalized) with epileptiform EEG discharges (if the anomalies
are localized); (b) variable EEG abnormalities may be observed
without a specific EEG or clinical headache pattern required;
(c) headache and EEG abnormalities immediately resolved after
antiepileptic drugs intravenous administration (Table 1).
However, these criteria have not been fully taken into account
into the recent revised ICHD-3 (17), thus creating confusion.
However, we feel that even if the concomitant appearance of
the EEG epileptiform discharges with headache is the mainstay
criteria for the diagnosis of IEH, the prompt response to
antiepileptic treatment is still crucial to confirm the clinical
suspicion (34).
Coci and Riedel recently described two patients, with chronic
headache unresponsive to analgesics therapy and disappeared
after oral antiepileptic therapy (24). An ictal EEG recording
in these adolescents during a headache attack revealed diffuse
spike-wave and poly-spikes, and spontaneous drug withdrawal
resulted in a recurrence of the headache, which resolved again
on anticonvulsant therapy. These authors classified these cases as
“probable IEH” due to the lack of clinical-EEG demonstration of
the resolution of both the headache and EEG anomalies, after the
administration of intravenous anticonvulsant therapy. Therefore,
although an EEG recording may not be routinely recommended
in children with headache, it should be performed promptly
in patients with prolonged headache that do not respond
to anti-migraine therapy (35–39), particularly in children
with epilepsy that also express other types of seizures (34).
Nevertheless, the use of clear-cut IEH criteria (3) will facilitate
communication among clinicians and researchers, avoiding






BETWEEN HEADACHE AND EPILEPSY
Several data support the view that increased neocortical
excitability is the leading mechanism underlying headache and
epilepsy (53). Taking into account that in migraine, during the
“spreading depression,” hypo- and hyper-excitation occur, both
(sequentially), as rebound phenomena, it could be suggested the
term “dys-excitability” to better describe these physiopathologic
events, rather than generically “hyperexcitability” (5, 6, 50, 54–
57). Cortical Spreading Depression (CSD), that many Authors
believe to be the most likely pathophysiological link between
headache and epilepsy (5, 6, 36, 39, 40, 58, 59), is a slowly
propagating wave of strong neuronal depolarization which
induces fleeting (but intense) spike activity, followed by a
neural suppression, lasting for minutes. The depolarization
proceeds simultaneously with an increased regional cerebral
blood flow, while the phase of reduced neural activity is
associated with a decrease in brain perfusion. CSD starts
the trigeminovascular system, provoking the release of many
inflammatory molecules and neurotransmitters, responsible for
the pain characterizing the headache phase (50, 60). Both,
basic and clinical neurosciences findings, are in favor of
“CSD” and “epileptic focus” as phenomenons able to facilitate
reciprocally each other, although with different effectiveness and
efficiency. The achievement of a minimum threshold necessary
to start depolarization is the key to both phenomenas, but,
the required threshold is presumed to be lower for CSD
than for an epileptic discharge, the onset of both facilitating
each other, anyway. This may explain why it is far more
likely to observe an epileptic subject who also presents a
peri-ictal headache than a cephalalgic patient who presents
epilepsy (36, 40, 43, 50, 53, 57, 60). The two phenomena
(CSD and epileptic seizure) possibly being triggered by more
than one pathway converging upon the same destination:
depolarization/dysexcitability (36, 40, 48, 50, 61).
The etiology could be environmental or individual
(due genetic causes or not), originating a flow of
ions that provokes CSD through neuronal and glial
cytoplasmic bridges, rather than through interstitial
ways as conversely occurs in the spreading of epileptic
seizures (5, 50, 55, 56, 62).
Both migraine and epilepsy have an important genetic
component, with strong evidence pointing to a shared
genetic basis between headache and epilepsy emerging from
clinical/EEG and genetic studies on Familial Hemiplegic
Migraine (FHM) (63–69). Recent data suggest shared
genetic substrates and phenotypic-genotypic correlations
with mutations in some ion transporter genes, including
CACNA1A, ATP1A2, and SCN1A (69–73). Other genetic
findings pointing to a link between migraine and epilepsy
have been published (74, 75). In addition, glutamate
metabolism (76), serotonin metabolism (77), dopamine
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TABLE 1 | Proposed original criteria for Ictal Epileptic Headache (IEH) [reproduce from Parisi et al. (3), with permission].
Diagnostic criteria A–D must all be fulfilled in IEH
A. Headache* lasting minutes, hours, or days
B. Headache that is ipsilateral or contralateral to lateralized ictal epileptiform EEG discharges (if EEG discharges are lateralized)
B. Evidence of epileptiform (focal **, lateralized or generalized) discharges on scalp EEG concomitantly with headache; different types of EEG anomalies may be observed
(generalized spike-and-wave or polyspike-and-wave, focal or generalized rhythmic activity or focal sub-continuous spikes or theta activity that may be intermingled
with sharp waves) with or without photoparoxysmal responses (PPRs)
D. Headache and EEG abnormalities resolves immediately (within few minutes) after i.v. antiepileptic drugs administration
*A specific headache pattern is not required (MigraineWith orWithout Aura, or Tension-type headache are all accepted). **Any localization (frontal, temporal, parietal, occipital) is accepted.
metabolism (78), and ion channel (sodium, potassium, and
chloride) function might be impaired in both epilepsy and
migraine (69, 79).
IN MOST CASES IEH IS PROBABLY AN
“AUTONOMIC SEIZURE”
To clarify why headache could be the sole ictal epileptic
manifestation, we (3, 5, 6, 34) previously hypothesized that an
autonomic seizure remains purely autonomic if ictal neuronal
activation of non-autonomic cortical areas does not achieve
the symptomatogenic threshold (80). Accordingly, we suggested
that IEH should be considered an autonomic form of epilepsy,
like Panayiotopoulos syndrome, and, thus, people with long-
lasting IEH attacks may even fulfill the criteria for autonomic
status epilepticus (81). Although it is difficult to explain the
reasons for which IEH remains an isolated manifestation
lasting up to several hours or even days (13), one can
speculate that the threshold for ictal autonomic manifestations
could be lower from that required for motor-sensory areas,
as observed for autonomic seizures in pediatric age (e.g.,
Panayiotopoulos syndrome).
In addition, while the presence of epileptiform abnormalities
usually confirm the diagnosis of epilepsy, in IEH patients the
lack of clear epileptic spike-and-wave activity does not rule out
the diagnosis of epilepsy. The same diagnostic difficulties arise
for patients with a deep epileptic focus arising, for example,
from the orbito-mesial frontal zone (82). In such cases, ictal
epileptic EEG activity may be recorded exclusively by means
of deep stereo-EEG recording, even, sometimes, purely by
chance (83).
Another crucial point is the lack of a clear, repetitive EEG
headache-associated pattern, owing to the fact that the ictal EEG
recording is usually not associated with specific EEG picture.
Indeed, different EEG patterns have been recorded during
headache-like complaints in both symptomatic and idiopathic
IEH cases (18, 20, 28–34).
Moreover, when EEG abnormalities are recorded, no specific
cortical correlations emerge (e.g., focal frontal, parietal, temporal,
occipital and primary or secondary generalized), as reported
(confirming, thus, our hypothesis) for autonomic manifestations
in Panayiotopoulos syndrome.
Accordingly, we may interpret a headache as the sole
expression of an epileptic seizure, supporting thus the autonomic
nature of the IEH, at least in the most of the cases.
FURTHER NEUROPHYSIOPATHOLOGICAL
REFLECTIONS ON THE POSSIBLE LINK
BETWEEN AUTONOMIC AND HEADACHE
PATHWAYS
To understand the complexity of the pathways and networks
involved in the onset and transmission of “primary headache”
from the periphery (intracranial vessels) within the central
nervous system until all potentially involved brain areas, you
have to sum up the main stages of such nociceptive structures,
fibers, pathways and such neuro-vascular structures. This careful
examination can make evident why is so difficult, at moment,
to classify the “Ictal Epileptic Headache” as “sensory” or
“autonomic” seizure to propose a precise classification in the new
Epilepsy classifications (84).
The cephalalgic attack originates as consequence of the
activation of nociceptors innervating pial, arachnoid, and dural
blood vessels, as well as large cortical arteries and sinuses. These
structures are activated by mechanical, electrical or chemical
stimulation (pro-inflammatory molecules, blood or infection),
causing a painful perception similar to migraine and its most
commonly associated symptoms/signs (nausea, throbbing pain,
photophobia, and phonophobia).
The intracranial vessels and the meninges are innervated by
unmyelinated fibers (C fibers) or thin little myelinated fibers
(Ad fiber), which convey nociceptive sensitivity; these axonal
terminations contain vasoactive neuropeptides such as substance
P (SP) and the peptide related to the calcitonin gene (CGRP).
They, originating from the trigeminal ganglion, reach the dura
through the ophthalmic branch of the trigeminal nerve (V1) and,
to a lesser extent, through the maxillary (V2) and mandibular
branches (V3).
The dura is also innervated by neurons located in the ganglia
of the upper cervical dorsal root. For decades, a possible vascular
origin of headache pain has been debated. At present, the results
of the various studies are conflicting and inconclusive, suggesting
that vascular changes would not have a primary role, or at
least, may not have a unique and predominant role in the
pathophysiology of headache (85–87).
The mechanisms that explain the efficacy of the Vagus Nerve
Stimulation (VNS) in the treatment of migraine and cluster
headaches are not yet clear; probably, it is realized through a
modulation of the intracranial trigeminal-vascular nociceptive
transmission. Most of the fibers of the vagus nerve includes
sensory afferents that terminate bilaterally in the nucleus tractus
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solitarius (NTS), before projecting into other nuclei, including
the locus coeruleus (LC), the nucleus of the dorsal raphe (DRN),
parabrachial nucleus, and PVN. It has been shown for the first
time that VNS inhibits nociceptive activation of trigeminal-
cervical neurons in preclinical models of acute dural-intracranial
(migraine-like) and trigeminal-autonomic (cluster) pain (87).
The insula and other part of so-called Limbic System (part of
frontal, temporal, and parietal regions which receive projections
from autonomic networks), have a role in various processes
including goal-directed cognition, conscious awareness,
autonomic regulation, enteroception, and somatosensation.
There are complex behaviors in migraine (conscious awareness
and error detection), which are less investigated of other
well-known, such as autonomic and somatosensory alterations
during the clinical attacks. The insula processes and relays
afferent inputs from brain areas involved in these functions,
to areas involved in higher cortical function, such as frontal,
temporal, and parietal regions. Insula role could be to decode
the signals of altered internal milieu in migraine (along with
other chronic pain conditions), taking into account the insula
role in translating and integrating of multiple informations into
complex behaviors (88).
It is also important to remember that, the activation of lateral
and ventrolateral periacqueduttal gray (PAG) neurons by direct
ascending lamina I e II projections (where make connection
the afferent fibers C amyelinic which comes from cerebral
vessels, as proposed for trigemino-vascular theory to explain
physiopathology of migraine), produces non-selective, non-
specific headache pain relief, cardiovascular reactions (decrease
in blood pressure), homeostatic reactions (temperature changes),
and defensive reactions (immobility, arousal, avoidance behavior,
and vocalization), as well as a more general emotional state
of fear and anxiety (89). Since the PAG undoubtedly projects
a more dense fiber connections to the rostral ventromedial
medulla (RVM), but minimally to the spinal and medullary
dorsal horn, RVM neurons constitute a direct link for descending
modulation through bilateral projections to all levels of spinal
and medullary dorsal horns. These functional and anatomical
studies are consistent with a broader modulatory role of
the PAG–RVM circuit and suggest an “absence of specificity”
for headache.
CONCLUSIONS
IEH does not have a specific clinical picture of headache/migraine
(migraine without aura or tension-type headache or aspecific
headache patterns, have all been reported), and it can last from
seconds to days, with evidence of synchronous ictal epileptiform
EEG anomalies; different EEG patterns may be observed, with
or without a photoparoxysmal response (see Table 1). In fact,
in particular, the ictal EEG recording in most patients does not
yield a particular EEG pattern or specific cortical topographic
correlations (focal frontal, parietal, temporal, occipital, and
focal with primary or secondary generalization, have all been
reported). EEG recording is not recommended routinely in
children with headache but should be considered promptly
in case of prolonged migraine/headache not responsive to
antimigraine drugs. If the main IEH criterion (EEG-clinical
response to antiepileptic intravenous administration) is not
satisfied, we can just pose a “probable IEH” diagnosis. The
concept of migralepsy is potentially confusing and should not
be used to describe the sequence of visual aura-seizure and an
ictal EEG recording is mandatory in these patients to exclude
an “hemicrania epileptica” (16).
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